Ursodeoxycholic Acid Prophylaxis During Incretin‐Based Obesity Management: An Evidence Gap Worth Addressing?

Mohammad Kermansaravi, Ricardo V. Cohen
Diabetes, Obesity and Metabolism · Wiley · 2026-11-16 · DOI: 10.1111/dom.71559

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles